Difference between revisions of "Documentation/Nightly/Modules/DSC MRI Analysis"
Stevedaxiao (talk | contribs) (Created page with '<noinclude>{{documentation/versioncheck}}</noinclude> <!-- ---------------------------- --> {{documentation/{{documentation/version}}/module-header}} <!-- -----------------------…') |
Stevedaxiao (talk | contribs) |
||
(3 intermediate revisions by the same user not shown) | |||
Line 58: | Line 58: | ||
|[[Image:DSC GUI V0.png|thumb|400px|DSC MRI Analysis GUI]] | |[[Image:DSC GUI V0.png|thumb|400px|DSC MRI Analysis GUI]] | ||
| | | | ||
− | *'''Input''' | + | * '''PkModeling Parameters''': |
− | ** ''' | + | ** '''CBF/CBV Time Interval Value''': Time interval for CBF/CBV calculation. |
+ | ** '''Use Population AIF''': A mean AIF is calculated from a functional form instead of from the input using the aifMask or a prescribed AIF. | ||
+ | * '''IO''' | ||
+ | ** '''Input 4D image''': 4D DSC MRI Image. | ||
+ | ** '''ROI Mask Image''': Mask designating the location for DSC analysis. | ||
+ | ** '''AIF Mask Image''': Mask designating the location of the arterial input function (AIF). AIF can either be calculated from the input using the aifMask, prescribed directly in concentration units using the prescribedAIF option, or via a population AIF. | ||
+ | ** '''Prescribed AIF''': Prescribed arterial input function (AIF). | ||
+ | ** '''Output K2 image''': Leakage map. | ||
+ | ** '''Output RCBV image''': Relative Cerebral Blood Volume (rCBV) map. | ||
+ | ** '''Output RCBF image''': Relative Cerebral Blood Flow (rCBF) map. | ||
+ | ** '''Output MTT image''': Mean Transit Time (MTT) map. | ||
+ | *'''Advanced options''' | ||
+ | ** '''BAT Calculation Mode''': PeakGradient(Default) or UseConstantBAT. | ||
+ | ** '''Constant BAT''': Constant bolus arrival time value. | ||
+ | ** '''Output Bolus Arrival Time Image''': The bolus arrival time calculated at each pixel. | ||
+ | ** '''Output Concentration 4D Image''': Delta R2* concentration image. | ||
+ | ** '''Output Fitted Data 4D Image''': Fitted Delta R2* concentration image. | ||
|} | |} | ||
Line 74: | Line 90: | ||
* [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657863/ Equations for conversion of signal to concentration for DSC] | * [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657863/ Equations for conversion of signal to concentration for DSC] | ||
* [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208985/pdf/nihms596683.pdf Other method to investigate DSC MRI] | * [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208985/pdf/nihms596683.pdf Other method to investigate DSC MRI] | ||
+ | * [http://www.ncbi.nlm.nih.gov/pubmed/16611779 Leakage correction for DSC MRI] | ||
<!-- ---------------------------- --> | <!-- ---------------------------- --> | ||
{{documentation/{{documentation/version}}/module-section|Information for Developers}} | {{documentation/{{documentation/version}}/module-section|Information for Developers}} | ||
{{documentation/{{documentation/version}}/module-developerinfo}} | {{documentation/{{documentation/version}}/module-developerinfo}} | ||
− | * [https://github.com/ | + | * [https://github.com/QIICR/DSC_Analysis Source code for analysis of DSC MRI] |
<!-- ---------------------------- --> | <!-- ---------------------------- --> |
Latest revision as of 22:22, 7 January 2016
Home < Documentation < Nightly < Modules < DSC MRI Analysis
For the latest Slicer documentation, visit the read-the-docs. |
Introduction and Acknowledgements
| |||||||
|
Module Description
Dynamic Susceptibility Contrast (DSC) MRI imaging is an important functional imaging method that enables quantitative assessment of tissue hemodynamic patterns. Abnormality of blood flow, volume and permeability is frequently observed during tumor growth, and characterization of these perfusion attributes has become clinically important for both diagnosis and therapy planning. In the context of glial neoplasms, perfusion characteristics have been shown to correlate with tumor type and grade and hence influence treatment decisions.
DSC MRI imaging is based on the principle that flow of a paramagnetic contrast agent through a capillary bed will transiently change the magnetic susceptibility of the given tissue. Decreased signal intensity on spin-echo or gradient-echo images after the first pass of the contrast agent, frequently described as susceptibility-induced T2* shortening, is the result of this temporal change in magnetic susceptibility. This signal time curve is then converted into a concentration time curve, and use of tracer kinetic analysis various hemodynamic variables, such as cerebral blood volume, cerebral blood flow, and mean transit time, as well as metrics that address vessel leakage may be estimated. Combined, these metrics enable microvascular imaging, providing a visual correlate of blood flow, volume, and vessel permeability.
Use Cases
- Estimation of quantitative parameters(rCBV,rCBF and MTT) from DSC MRI.
- Guide diagnosis, prognosis and therapy planning.
- Brain Tumor, Stroke, Adrenoleukodystrophy and other diseases.
Tutorials
Panels and their use
|
Similar Modules
References
- Introduction of DSC MRI from Siemens
- Equations for conversion of signal to concentration for DSC
- Other method to investigate DSC MRI
- Leakage correction for DSC MRI
Information for Developers
Section under construction. |